Skip to main content
SpringerLink
Log in

Breast Cancer Screening

  • Chapter
  • First Online:
Management of Breast Diseases

  • 1390 Accesses

Abstract

Breast cancer screening is a major public health issue. Decisions concerning breast cancer screening should be based upon the results of randomized controlled trials, not observational studies. There are three important biases associated with observational studies that examine the effect of screening: lead time, length, and selection biases. Randomized trials have shown that mammography screening reduces breast cancer-specific mortality in postmenopausal women. Additionally, randomized trials are underway to assess the efficacy of screening clinical breast examination (CBE) and screening breast ultrasound. Two large randomized trials have failed to demonstrate a benefit of screening breast self-examination (BSE) in reducing breast cancer-specific mortality. Screening breast MRI is often utilized in mutation carriers and those with increased risk of breast cancer based upon family history, but there are no randomized trials that have examined its efficacy. There are also potential hazards of screening that should be considered: lead time, false-positives, radiation exposure (from screening mammography), overdiagnosis, and cost. Women should be informed about both the potential risks and the benefits of breast cancer screening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. MacDonald I. Biological predeterminism in human cancer. Surg Gynecol Obstet. 1951;92:443–52.

    CAS  PubMed  Google Scholar 

  2. Black MM, Speer FD. Biological variability of breast carcinoma in relation to diagnosis and therapy. NY State J Med. 1953;53:1560–3.

    CAS  Google Scholar 

  3. Devitt JE. Breast cancer: have we missed the forest because of the tree? Lancet. 1994;344:734–5.

    Article  CAS  PubMed  Google Scholar 

  4. Haagensen CD. Diseases of the breast. Philadelphia: WB Saunders; 1956.

    Google Scholar 

  5. Jatoi I. Breast cancer screening. Am J Surg. 1999;177:518–24.

    Article  CAS  PubMed  Google Scholar 

  6. Jatoi I. Breast cancer: a systemic or local disease? Am J Clin Oncol. 1997;20:536–9.

    Article  CAS  PubMed  Google Scholar 

  7. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980;64:1263–72.

    CAS  PubMed  Google Scholar 

  8. Nielsen C, Lang RS. Principles of screening. Med Clin North Am. 1999;83:1323–37.

    Article  CAS  PubMed  Google Scholar 

  9. Anderson TJ, Lamb J, Alexander F, et al. Comparative pathology of prevalent and incident cancers detected by breast cancer screening: Edinburgh breast screening project. Lancet. 1986;1:519–23.

    Article  CAS  PubMed  Google Scholar 

  10. Gilliland FD, Joste N, Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancer. J Natl Cancer Inst. 2000;92:743–9.

    Article  CAS  PubMed  Google Scholar 

  11. Xu IL, Prorok PC. Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases. Stat Med. 1995;14:2715–25.

    Article  CAS  PubMed  Google Scholar 

  12. Black WC, Welch HG. Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328:1237–43.

    Article  CAS  PubMed  Google Scholar 

  13. Kiemi PJ, Joensuu H, Toikkanen S, et al. Aggressiveness of breast cancers found with and without screening. Br Med J. 1992;304:467–9.

    Article  Google Scholar 

  14. Schmidt JG. The epidemiology of mass breast cancer screening—a plea for a valid measure of benefit. J Clin Epidemiol. 1990;43:215–22.

    Article  CAS  PubMed  Google Scholar 

  15. Monsees BS, Destouet JM. A screening mammography program: staying alive and making it work. Radiol Clin North Am. 1992;30:211–9.

    CAS  PubMed  Google Scholar 

  16. Hurley SF, Kaldor JM. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev. 1992;14:101–30.

    Article  CAS  PubMed  Google Scholar 

  17. Salomon A. Beitrage zur pathologie und klinik der maminacrcinome. Arch f klin Chir. 1913;101:573–668.

    Google Scholar 

  18. Warren SL. A roentgenologic study of the breast. Am J Roentgenol. 1930;24:113–24.

    Google Scholar 

  19. Gershon-Cohen I, Ingleby H, Moore L. Can mass X-ray surveys be used in detection of early cancer of the breast? JAMA. 1956;161:1069–71.

    Article  CAS  Google Scholar 

  20. Gershon-Cohen I, Hermel MB, Berger SM. Detection of breast cancer by periodic X-ray examinations. JAMA. 1961;176:1114–6.

    Article  CAS  PubMed  Google Scholar 

  21. Egan RL. Mammography, an aid to diagnosis of breast carcinoma. JAMA. 1962;182:839–43.

    Article  Google Scholar 

  22. Fletcher SW, Black W, Harris R, et al. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst. 1993;85:1644–56.

    Article  CAS  PubMed  Google Scholar 

  23. Shapiro S, Venet W, Strax P, et al. Ten-to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69:349–55.

    CAS  PubMed  Google Scholar 

  24. Eddy DM, Hasselblad V, McGivney W, et al. The value of mammography screening in women under age 50 years. JAMA. 1988;259:1512–9.

    Article  CAS  PubMed  Google Scholar 

  25. Shapiro S, Venet W, Strax P, et al. Periodic screening for breast cancer: the health insurance plan project and its Sequelae, 1963–1986. Baltimore: Johns Hopkins University; 1988.

    Google Scholar 

  26. Nystrom L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet. 1993;34(l):973–8.

    Google Scholar 

  27. Organizing Committee and Collaborators. Breast cancer screening with mammography in women aged 40–49 years: report of the Organizing Committee and Collaborators, Falun Meeting, Falun, Sweden (21 and 22 March 1996). Int J Cancer. 1996;68:693–9.

    Article  Google Scholar 

  28. Hendrick RE, Smith RA, Rutlege JH, et al. Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst. 1997;22:87–92.

    Article  Google Scholar 

  29. Alexander FE, Anderson TI, Brown H, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer. 1994;70:542–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Alexander FE. The Edinburgh randomized trial of breast cancer screening. Monogr Natl Cancer Inst. 1997;22:31–5.

    Article  Google Scholar 

  31. Alexander FE, Anderson TI, Brown HK, et al. 14 years of follow-up from the Edinburgh randamised trial of breast cancer screening. Lancet. 1999;353:1903–8.

    Article  CAS  PubMed  Google Scholar 

  32. Miller AB, Baines CI, To T, et al. Canadian national breast screening study I. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J. 1992;147:1459–76.

    CAS  Google Scholar 

  33. Miller AB, Baines CJ, To T, et al. Canadian national breast screening study II. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J. 1992;147:1477–88.

    CAS  Google Scholar 

  34. Miller AB, To T, Baines CI, Wall C. Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst. 2000;92:1490–9.

    Article  CAS  PubMed  Google Scholar 

  35. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. Br Med J. 2014;348:g366.

    Article  Google Scholar 

  36. Mosss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Trial management group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomized controlled trial. Lancet. 2006;368(9552):2053–60.

    Article  Google Scholar 

  37. Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years’ follow-u: a randomised controlled trial. Lancet Oncology. 2015;16:1123–32.

    Article  PubMed  Google Scholar 

  38. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273:149–54.

    Article  CAS  PubMed  Google Scholar 

  39. Smart CR, Hendrick RE, Rutledge JH III, et al. Benefit of mammography screening in women ages40 to 49 years: current evidence from randomized controlled trials. Cancer. 1995;75:1619–25.

    Article  CAS  PubMed  Google Scholar 

  40. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med. 2002;137:347–60.

    Article  PubMed  Google Scholar 

  41. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355:129–34.

    Article  CAS  PubMed  Google Scholar 

  42. Duffy SW, Tabar L. Screening mammography re-evaluated. Lancet. 2000;355:747–8.

    Article  CAS  PubMed  Google Scholar 

  43. Dean PB. Final comment. The articles by Gotzsche and Olsen are not Official Cochrane reviews and lack scientific merit. Lakartidningen. 2000;97:3106.

    CAS  PubMed  Google Scholar 

  44. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2006;(4):CD001877.

    Google Scholar 

  45. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 2016;164(4):1–12.

    Article  Google Scholar 

  46. Jatoi I. The case against mammographic screening for women in their forties. In: Jatoi I, editor. Breast cancer screening. Austin: Landes Biosciences; 1997. p. 35–49.

    Google Scholar 

  47. Jatoi I, Baum M. American and European recommendations for screening mammography in younger women: a cultural divide? RMJ. 1993;307:1481–3.

    CAS  Google Scholar 

  48. Davis DL, Love SM. Mammographic screening. JAMA. 1994;271:152–3.

    Article  CAS  PubMed  Google Scholar 

  49. Fletcher SW. Breast cancer screening among women in their forties: an overview of the issues. Monogr Natl Cancer Inst. 1997;22:5–9.

    Article  Google Scholar 

  50. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 40 to 69 years: comparison of relative and absolute benefit. Monogr Natl Cancer Inst. 1997;22:79–86.

    Article  Google Scholar 

  51. de Koning HJ, Boer R, Warmerdam PG, et al. Quantitative interpretations of age-specific mortality reductions from the Swedish breast cancer screening trials. J Nati Cancer Inst. 1995;87:1217–23.

    Article  Google Scholar 

  52. Kopans DB. The case in favor of mammographic screening for women in their forties. In: Jatoi I, editor. Breast cancer screening. Austin: Landes Biosciences; 1997. p. 9–34.

    Google Scholar 

  53. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials. 1993 (Doc No. 32).

    Google Scholar 

  54. Clemmensen J. Carcinoma of the breast: results from statistical research. Br J Radiol. 1948;21:583.

    Article  Google Scholar 

  55. Jatoi I, Anderson WF, Rosenberg PS. Qualitative age-interactions in breast cancer: a tale of two diseases? Am J Clin Oncol. 2008;31:504–6.

    Article  PubMed  Google Scholar 

  56. Willett W. Nutritional epidemiology. New York: Oxford University; 1990.

    Google Scholar 

  57. Henderson IC. Biologic variations of tumors. Cancer. 1992;69:1888–95.

    Article  CAS  PubMed  Google Scholar 

  58. Baines CJ. Mammography screening: are women really giving informed consent? J Natl Cancer Inst. 2003;95(20):1512–3.

    Article  PubMed  Google Scholar 

  59. Tabar L, Fagerberg G, Day NE, et al. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer. 1987;55:547–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Leitch AM, Dodd GD, Constanza M, et al. American cancer society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 1997;47:150–3.

    Article  CAS  PubMed  Google Scholar 

  61. Larsson LG, Nystrom L, Wall S, et al. The Swedish randomized mammography screening trials. J Med Screen. 1996;3:129–32.

    Article  CAS  PubMed  Google Scholar 

  62. Kerlikowske K, Salzmann P, Phillips KA, et al. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999;282:2156–63.

    Article  CAS  PubMed  Google Scholar 

  63. Jatoi I, Miller AB. Breast cancer screening in elderly women: primum non nocere. JAMA Surgery. 2015;150(12):1107–8.

    Article  PubMed  Google Scholar 

  64. Jatoi I, Miller AB. Why is breast cancer mortality declining? Lancet Oncology. 2003;4:251–4.

    Article  PubMed  Google Scholar 

  65. Jatoi I. The impact of advances in treatment on the efficacy of mammography screening. Prev Med. 2011;53:103–4.

    Article  PubMed  Google Scholar 

  66. Kuhl CK. The “coming of age” of nonmammographic screening for breast cancer. JAMA. 2008;299(18):2203–5.

    Article  CAS  PubMed  Google Scholar 

  67. Berg WA, Blume JD, Cormack JB. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Tohno E, Ueno E, Watanabe H. Ultrasound screening of breast cancer. Breast Cancer. 2009;16(1):18–22.

    Article  PubMed  Google Scholar 

  69. Ohuchi N, Suzuki A, Sobue T, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016;387:341–8.

    Article  PubMed  Google Scholar 

  70. Jatoi I, Anderson WF. Management of women who have a genetic predisposition for breast cancer. Surg Clin North Am. 2008;88(4):845–61.

    Article  PubMed  Google Scholar 

  71. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351(5):427–37.

    Article  CAS  PubMed  Google Scholar 

  72. Saslow D, Boetes C, Burke W, et al. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89.

    Article  PubMed  Google Scholar 

  73. Bums RB, Freund KM, Ash AS, et al. As mammography use increases, are some providers omitting clinical breast examination? Arch Intern Med. 1996;156:741–4.

    Article  Google Scholar 

  74. Saslow D, Hannan J, Osuch J, et al. Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin. 2004;54:327–44.

    Article  PubMed  Google Scholar 

  75. Mittra I, Baum M, Thornton H, et al. Is clinical breast examination an acceptable alternative to mammographic screening? BMJ. 2000;321:1071–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Report of the Working Group to review the National Cancer Institute-American Cancer Society breast cancer detection demonstration projects. J Nati Cancer Inst. 1979;62:639–709.

    Google Scholar 

  77. Pisani P, Parkin DM, Ngelangel C, Esteban D, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006;118(1):149–54.

    Article  CAS  PubMed  Google Scholar 

  78. Barton MB, Harris R, Fletcher SW. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282:1270–80.

    Article  CAS  PubMed  Google Scholar 

  79. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2003;2(CD003373). doi:10.1002/14651858.CD003373.

  80. Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010;126:976–84.

    CAS  PubMed  Google Scholar 

  81. Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011;103:1–5.

    Article  Google Scholar 

  82. Adair FE. Clinical manifestations of early cancer of the breast—with a discussion on the subject of biopsy. N Engl J Med. 1933;208:1250–5.

    Article  Google Scholar 

  83. Semiglazov VF, Moiseyenko VM, Bavli JL, Migmanova N, et al. The role of breast self-examination in early breast cancer detection (results of the 5-year USSR/WHO randomized study in Leningrad). Eur J Epidemiol. 1992;8(4):498–502.

    Article  CAS  PubMed  Google Scholar 

  84. Semiglazov VF, Moiseyenko VM, Manikhas AG, Protsenko SA, Kharikova RS, Ivanow VG, et al. Role of breast self-examination in early detection of breast cancer: Russia/WHO prospective randomized trial in St. Petersburg. Cancer Strategy. 1999;1:145–51.

    Google Scholar 

  85. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of breast self-examination: final results. J Natl Cancer Inst. 2002;94(19):1445–57.

    Article  PubMed  Google Scholar 

  86. Fletcher SW, Elmore JG. False-positive mammograms—can the USA learn from Europe? Lancet. 2005;365:7–8.

    Article  PubMed  Google Scholar 

  87. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false-positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089–96.

    Article  CAS  PubMed  Google Scholar 

  88. Hofvind S, Thorsen S, Tretli S. The cumulative risk of a false-positive recall in the Norwegian breast cancer screening program. Cancer. 2004;101:1501–7.

    Article  PubMed  Google Scholar 

  89. Schwartz LM, Woloshin S, Sox HC, et al. U.S. women’s attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320:1635–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Jatoi I, Zhu K, Shah M, Lawrence W. Psychological distress in U.S. women who have experienced false-positive mammograms. Breast Cancer Res Treat. 2006;101:191–200.

    Article  Google Scholar 

  91. Bailar JC. Mammography: a contrary view. Ann Intern Med. 1976;84:77–84.

    Article  PubMed  Google Scholar 

  92. Beemsterboer PM, Warmerdam PG, Boer R, et al. Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen. 1998;5:81–7.

    Article  CAS  PubMed  Google Scholar 

  93. Swift M, Morrell D, Massey RB, et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991;325:1831–6.

    Article  CAS  PubMed  Google Scholar 

  94. Werneke U. Ataxia telangiectasia and risk of breast cancer. Lancet. 1997;350:739–40.

    Article  CAS  PubMed  Google Scholar 

  95. Robson M, Offit K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med. 2007;357(2):154–62.

    Article  CAS  PubMed  Google Scholar 

  96. Vaidya JS, Baum M. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. JAMA. 1997;278:290.

    Article  CAS  PubMed  Google Scholar 

  97. Pijpe A, Andrieu N, Easton DF, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA ½ mutations: retrospective cohort study (GENE-RAD-RISK). Br Med J. 2012;345:1–15.

    Article  Google Scholar 

  98. de Gonzalez AM, Berg CD, Visvanathan K, Robson M. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst. 2009;101:205–9.

    Article  Google Scholar 

  99. Peeters PH, Verbeek AL, Straatman H, et al. Evaluation of over-diagnosis of breast cancer in screening with mammography: results of the Nijmegen programme. Int J Epidemiol. 1989;18:295–9.

    Article  CAS  PubMed  Google Scholar 

  100. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. Br Med J. 2006;332(7543):689–92.

    Article  Google Scholar 

  101. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast cancer incidence. N Engl J Med. 2012;367:1998–2005.

    Article  CAS  PubMed  Google Scholar 

  102. Zahl P, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 2008;168(21):2311–6.

    Article  PubMed  Google Scholar 

  103. Jatoi I, Baum M. Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery. 1995;118:118–20.

    Article  CAS  PubMed  Google Scholar 

  104. Welch HG, Woloshin S, Schwartz LM. The sea of uncertainty surrounding ductal carcinoma in situ—the price of screening mammography. J Natl Cancer Inst. 2008;100(4):228–9.

    Article  PubMed  Google Scholar 

  105. Moore MM. Treatment of ductal carcinoma in situ of the breast. Semin Surg Oncol. 1991;7:267–70.

    Article  CAS  PubMed  Google Scholar 

  106. Emster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913–8.

    Article  Google Scholar 

  107. Nielsen M, Thomsen JL, Primdahl S, et al. Breast cancer and atypia among young and middle aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56:814–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Rosen PR, Braun DW Jr, Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer. 1980;46:919–25.

    Article  CAS  PubMed  Google Scholar 

  109. Page DL, Dupont WD, Rogers LW, et al. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751–8.

    Article  CAS  PubMed  Google Scholar 

  110. Alpers CE, Wellings SR. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol. 1985;16:796–807.

    Article  CAS  PubMed  Google Scholar 

  111. Kattlove H, Liberati A, Keeler B, et al. Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package. JAMA. 1995;273:142–8.

    Article  CAS  PubMed  Google Scholar 

  112. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008;100:1290–300.

    Article  PubMed  Google Scholar 

  113. Black WC, Nease RF, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 1995;87:720–31.

    Article  CAS  PubMed  Google Scholar 

  114. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–92.

    Article  CAS  PubMed  Google Scholar 

  115. Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol. 2007;25(13):1683–90.

    Article  PubMed  Google Scholar 

  116. Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 2006;23(31):7836–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology and Endocrine Surgery, University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 7738, San Antonio, TX, 78229, USA

    Ismail Jatoi

Authors
  1. Ismail Jatoi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ismail Jatoi .

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Texas Health Science Center, San Antonio, Texas, USA

    Ismail Jatoi

  2. Obstetrics and Gynecology, University Medical Center Schleswig-Holstein, Luebeck, Germany

    Achim Rody

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jatoi, I. (2016). Breast Cancer Screening. In: Jatoi, I., Rody, A. (eds) Management of Breast Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-46356-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46356-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46354-4

  • Online ISBN: 978-3-319-46356-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation